Generation of Chimeric RNAs by cis-splicing of adjacent genes (cis-SAGe) in mammals
Received date: 2017-05-31
Revised date: 2017-07-31
Online published: 2018-02-01
Supported by
the Foundation for Improving Innovation Ability of Scientific Research Institution of Heilongjiang Province(YC2016D001);Scientific Research Foundation for the Returned Overseas Chinese Scholars of Heilongjiang Province(LC201412)
Chimeric RNA molecules, possessing exons from two or more independent genes, are traditionally believed to be produced by chromosome rearrangement. However, recent studies revealed that cis-splicing of adjacent genes (cis- SAGe) is one of the major mechanisms underlying the formation of chimeric RNAs. cis-SAGe refers to intergenic splicing of directly adjacent genes with the same transcriptional orientation, resulting in read-through transcripts, termed chimeric RNAs, which contain sequences from two or more parental genes. cis-SAGe was first identified in tumor cells, since then its potential in carcinogenesis has attracted extensive attention. More and more scientists are focusing on it. With the development of research, cis-SAGe was found to be ubiquitous in various normal tissues, and might make a crucial contribution to the formation of novel genes in the evolution of genomes. In this review, we summarize the splicing pattern, expression characteristics, possible mechanisms, and significance of cis-SAGe in mammals. This review will be helpful for general understanding of the current status and development tendency of cis-SAGe.
Jianshu Zhuo, Xiaoyan Jing, Xin Du, Xiuqin Yang . Generation of Chimeric RNAs by cis-splicing of adjacent genes (cis-SAGe) in mammals[J]. Hereditas(Beijing), 2018 , 40(2) : 145 -154 . DOI: 10.16288/j.yczz.17-197
| [1] | Ge HY , Liu KJ , Juan T , Fang F , Newman M , Hoeck W . FusionMap: detecting fusion genes from next-generation sequencing data at base-pair resolution. Bioinformatics, 2011, 27( 14): 1922- 1928. |
| [2] | Gerstein MB , Bruce C , Rozowsky JS , Zheng DY , Du J , Korbel JO , Emanuelsson O , Zhang ZD , Weissman S , Snyder M . What is a gene, post-ENCODE? History and updated definition. Genome Res, 2007, 17( 6): 669- 681. |
| [3] | Gingeras TR . Implications of chimaeric non-co-linear transcripts. Nature, 2009, 461( 7261): 206- 211. |
| [4] | Rowley JD . Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature, 1973, 243( 5405): 290- 293. |
| [5] | Skapek SX , Anderson J , Barr FG , Bridge JA , Gastier- Foster JM , Parham DM , Rudzinski ER , Triche T , Hawkins DS . PAX-FOXO1 fusion status drives unfavorable outcome for children with rhabdomyosarcoma: a children's oncology group report. Pediatr Blood Cancer, 2013, 60( 9): 1411- 1417. |
| [6] | Missiaglia E , Williamson D , Chisholm J , Wirapati P , Pierron G , Petel F , Concordet JP , Thway K , Oberlin O , Pritchard-Jones K , Delattre O , Delorenzi M , Shipley J . PAX3/FOXO1 fusion gene status is the key prognostic molecular marker in rhabdomyosarcoma and significantly improves current risk stratification. J Clin Oncol, 2012, 30( 14): 1670- 1677. |
| [7] | Jothi M1, Mal M, Keller C, Mal AK. Small molecule inhibition of PAX3-FOXO1 through AKT activation suppresses malignant phenotypes of alveolar rhabdomyosarcoma. Mol Cancer Ther, 2013, 12( 12): 2663- 2674. |
| [8] | Loupe JM , Miller PJ , Ruffin DR , Stark MW , Hollenbach AD . Inhibiting phosphorylation of the oncogenic PAX3- FOXO1 reduces alveolar rhabdomyosarcoma phenotypes identifying novel therapy options. Oncogenesis, 2015, 4( 3): e145. |
| [9] | Williamson D , Missiaglia E , De Reyniès A , Pierron G , Thuille B , Palenzuela G , Thway K , Orbach D , Laé M , Fréneaux P , Pritchard-Jones K , Oberlin O , Shipley J , Delattre O . Fusion gene-negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma. J Clin Oncol, 2010, 28( 13): 2151- 2158. |
| [10] | Tognon C , Knezevich SR , Huntsman D , Roskelley CD , Melnyk N , Mathers JA , Becker L , Carneiro F , MacPherson N, Horsman D, Poremba C, Sorensen PHB. Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma. Cancer Cell, 2002, 2( 5): 367- 376. |
| [11] | Persson M , Andrén Y , Mark J , Horlings HM , Persson F , Stenman G . Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck. Proc Natl Acad Sci USA, 2009, 106( 44): 18740- 18744. |